Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel G Haller

Showing results (91-100 of 112) with videos related to

Pageof 12
Sort By:
International Journal of Radiation Oncology, Biology, Physics|September 24, 2002
Impact of T and N substage on survival and disease relapse in adjuvant rectal cancer: a pooled analysisLeonard L Gunderson, Daniel J Sargent, Joel E Tepper, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
A Phase I trial of the farnesyltransferase inhibitor L-778,123 and radiotherapy for locally advanced lung and head and neck cancerStephen M Hahn, Eric J Bernhard, William Regine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2012
Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resectionStephen R Smalley, Jacqueline K Benedetti, Daniel G Haller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2007
New approaches to assessing and treating early-stage colon and rectal cancer: summary statement from 2007 Santa Monica ConferenceLee S Rosen, Anton J Bilchik, Robert W Beart, et al.
Pharmacogenetics and Genomics|June 21, 2021
Pharmacogenetic study in gastric cancer patients treated with adjuvant fluorouracil/leucovorin or epirubicin/cisplatin/fluorouracil before and after chemoradiation on CALGB 80101 (Alliance)Jai N Patel, Chen Jiang, Kouros Owzar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2004
Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?Sharlene Gill, Charles L Loprinzi, Daniel J Sargent, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2006
Phase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer: a planned safety analysis in 1,864 patientsHans-Joachim Schmoll, Thomas Cartwright, Josep Tabernero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2007
Priorities in colorectal cancer research: recommendations from the Gastrointestinal Scientific Leadership Council of the Coalition of Cancer Cooperative GroupsPeter J O'Dwyer, S Gail Eckhardt, Daniel G Haller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 26, 2011
Future directions in the treatment of neuroendocrine tumors: consensus report of the National Cancer Institute Neuroendocrine Tumor clinical trials planning meetingMatthew H Kulke, Lillian L Siu, Joel E Tepper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2007
Phase II trial of sunitinib in patients with metastatic colorectal cancer after failure of standard therapyLeonard B Saltz, Lee S Rosen, John L Marshall, et al.
Pageof 12

Showing results (91-100 of 112) with videos related to

Sort By:
Pageof 12
International Journal of Radiation Oncology, Biology, Physics|September 24, 2002
Impact of T and N substage on survival and disease relapse in adjuvant rectal cancer: a pooled analysisLeonard L Gunderson, Daniel J Sargent, Joel E Tepper, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
A Phase I trial of the farnesyltransferase inhibitor L-778,123 and radiotherapy for locally advanced lung and head and neck cancerStephen M Hahn, Eric J Bernhard, William Regine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2012
Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resectionStephen R Smalley, Jacqueline K Benedetti, Daniel G Haller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2007
New approaches to assessing and treating early-stage colon and rectal cancer: summary statement from 2007 Santa Monica ConferenceLee S Rosen, Anton J Bilchik, Robert W Beart, et al.
Pharmacogenetics and Genomics|June 21, 2021
Pharmacogenetic study in gastric cancer patients treated with adjuvant fluorouracil/leucovorin or epirubicin/cisplatin/fluorouracil before and after chemoradiation on CALGB 80101 (Alliance)Jai N Patel, Chen Jiang, Kouros Owzar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2004
Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?Sharlene Gill, Charles L Loprinzi, Daniel J Sargent, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2006
Phase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer: a planned safety analysis in 1,864 patientsHans-Joachim Schmoll, Thomas Cartwright, Josep Tabernero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2007
Priorities in colorectal cancer research: recommendations from the Gastrointestinal Scientific Leadership Council of the Coalition of Cancer Cooperative GroupsPeter J O'Dwyer, S Gail Eckhardt, Daniel G Haller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 26, 2011
Future directions in the treatment of neuroendocrine tumors: consensus report of the National Cancer Institute Neuroendocrine Tumor clinical trials planning meetingMatthew H Kulke, Lillian L Siu, Joel E Tepper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2007
Phase II trial of sunitinib in patients with metastatic colorectal cancer after failure of standard therapyLeonard B Saltz, Lee S Rosen, John L Marshall, et al.
Pageof 12